Osteoarthritis (OA) is the most common form of arthritis, affecting 1 in 3 people over the age of 65. It is the third most rapidly rising cause of disability and the most common reason for decrease in ambulation. With the onset of the COVID-19 pandemic, the US Surgeon General has recommended cancelling elective surgeries, causing a large impact on patients with OA. A survey of 360 patients at 6 surgical centers who had to cancel their hip or knee surgery revealed that 30% would have surgery despite COVID-19 risks, 15% had no help at home, and 21% felt isolated or lonely.
COVID-19 has also led to an accelerated uptake of telehealth, and its utilization in the management of OA has shown that it is cost effective, efficacious and accurate, and has a high patient satisfaction rate. However, there are challenges to its usage, including technology literacy, implementation, inability to perform examination, and regulatory barriers, which have led to the need for education.
The final installment in this CME Outfitters Snack series on managing OA focuses on best practices for utilizing telehealth, including encouraging patients to maximize mobility in time of isolation, increasing the utilization of video in telehealth and wearable tech, and the consideration of both operative and non-operative measures for treatment.
At the end of this CME/CE activity, participants should be able to apply strategies to manage OA during the COVID-19 pandemic.
The following learning objectives pertain only to those requesting CNE or CPE credit identify strategies to management OA during the COVID-19 pandemic.
Supported by an educational grant from Pfizer Inc.
Physicians, PAs, nurse practitioners, and pharmacists.
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Wilcox reports that he is a stock shareholder (directly purchased) of Pfizer Inc.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
NOTE: Pharmacist CE Universal Activity Number, Enduring: JA0007185-0000-21-099-H01-P.
Call us at 877.CME.PROS (877.263.7767).